Drug
Ctx130
Ctx130: highest development phase Phase 1, developed by CRISPR Therapeutics. 2 trial records tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- CRISPR Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| CTX130 NCT04502446 | Phase 1 | T Cell Lymphoma |
| CTX130 NCT04438083 | Phase 1 | Renal Cell Carcinoma |
Latest
No recent events.
Follow Ctx130 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.